Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

Bengala, C; Guarneri, V; Giovannetti, E; Lencioni, M; Fontana, E; Mey, V; Fontana, A; Boggi, U; Del Chiaro, M; Danesi, R; Ricci, S; Mosca, F; Del Tacca, M; Conte, P F

Bengala, C; Guarneri, V; Giovannetti, E; Lencioni, M; Fontana, E; Mey, V; Fontana, A; Boggi, U; Del Chiaro, M; Danesi, R; Ricci, S; Mosca, F; Del Tacca, M; Conte, P F.

Affiliation

Bengala C; Department of Oncology and Hematology, Division of Medical Oncology, University of Modena and Reggio Emilia, Via del Pozzo71, Modena 41100, Modena, Italy. bengala.carmelo@policlinico.mo.it

Br J Cancer ; 93(1): 35-40, 2005 Jul 11.

Article in En | MEDLINE | ID: mdl-15986033

Subject(s)

Adenocarcinoma/therapy; Hematopoietic Stem Cell Transplantation; Pancreatic Neoplasms/therapy; Adenocarcinoma/drug therapy; Adult; Aged; Base Sequence; Combined Modality Therapy; DNA Primers; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms/drug therapy; Pharmacogenetics; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Hematopoietic Stem Cell Transplantation Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google